• Home
  • Latest Articles
  • Explore Topics
  • Resources
Lightbulb icon

Healthcare Innovation

Card image
October 2021

The Science of Possibilities: mRNA Beyond COVID Vaccines

William Blair analysts discuss the latest biotech technologies that are driving investments
Card image
December 2020

William Blair Biotech Equity Research Head Discusses Outlook for COVID-19 Vaccines

Tim Lugo discusses unprecedent efforts of vaccine development
Card image
March 2021

Justin Ullman—Changing the World Bit by Bit

Tech entrepreneur leads University of Chicago Cancer Research Board
Card image
June 2020

Q&A on Coronavirus Testing with William Blair’s Equity Analyst Brian Weinstein

Lead equity analyst covering COVID-19 diagnostics shares latest developments
Card image
June 2020

Digitization of Healthcare in America

VIDEO: Investment banker Joe Schauenberg discusses healthcare technology
Card image
April 2020

William Blair’s Biotech Equity Research Head Answers COVID-19 Questions

Tim Lugo shares insights from a health and investment perspective
Card image
August 2018

Regenerative Medicine: Finding Ways for the Body to Heal Itself

No longer science fiction
Card image
August 2018

Dr. Richard Fessler Leads Breakthrough Research for Paralysis

For the first time, making progress in reversing spinal cord injury
Card image
August 2018

Regenerative Medicine: Early Innings, Exciting Gains

A look at companies leading the way

William Blair & Company and the script logo are registered trademarks of William Blair & Company, L.L.C.
William Blair & Company Client Focus ©
William Blair & Company, L.L.C. All rights reserved.
Member FINRA • Member SIPC

References to specific securities and their issuers are for illustrative purposes only and are not intended and should not be interpreted as recommendations. Past performance does not guarantee future results. This is not in any sense a solicitation or offer of the purchase or sale of securities. The factual statements herein have been taken from sources we believe to be reliable, but such statements are made without any representation as to accuracy or completeness or otherwise. Opinions expressed herein are our own unless otherwise stated and are current opinions as of the date appearing in this material only. These materials are subject to change without notice. From time to time, William Blair & Company, L.L.C. or its affiliates may buy and sell the securities referred to herein, may make a market therein, and may have long or short position therein. Prices shown are approximate. This material is distributed in the United Kingdom and European Economic Area (EEA) by William Blair International, Ltd., authorized and regulated by the Financial Conduct Authority (FCA), and is directed only at, and is only made available to, persons falling within Article 9, 38, 47, and 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (all such persons being referred to as “relevant persons”). This document is intended for persons regarded as professional investors (or equivalent) and is not to be distributed or passed on to any “retail clients”. No persons other than persons to whom this document is directed should rely on it or its contents or use it as the basis to make an investment decision.